GlassScriptPhysician profile
Anna Taylor Dodd
NPI 1083293914
$6,732.33
in general payments reported to CMS, 2019-2025
29 companies · $1,879 in 2025
The $1,879 reported for 2025 was more than what 93% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $366 · 2022: $609 · 2023: $1,961 · 2024: $1,917 · 2025: $1,879.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,757.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,756.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $1,064.70 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Glaxosmithkline, LLC. | $1,050.93 | 2023-2025 | Jemperli, Zejula |
| Eisai INC. | $945.45 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $612.51 | 2022-2025 | Lynparza, Evusheld |
| Abbvie INC. | $552.11 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $454.24 | 2022-2025 | Myrisk, Precisetumor |
| Caris Mpi, INC. | $343.30 | 2025 | Mi Cancer Seek |
| Seagen INC. | $260.44 | 2021-2023 | Tivdak |
| Immunogen, INC. | $246.65 | 2023-2024 | Elahere, Elahere |
| Tempus Ai, INC | $150.55 | 2024 | |
| Cumberland Pharmaceuticals, INC. | $124.50 | 2022-2023 | Sancuso |
| Astellas Pharma US INC | $122.74 | 2024-2025 | Veozah |
| Baxter Healthcare | $96.09 | 2023-2025 | Perclot, Floseal |
| Clovis Oncology, INC. | $81.46 | 2021-2022 | |
| Daiichi Sankyo INC. | $75.90 | 2024-2025 | Enhertu |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $69.00 | 2023 | Ova1 |
| Verastem, INC. | $68.20 | 2025 | Avmapki Fakzynja Co-Pack |
| Smith+Nephew, INC. | $65.26 | 2024 | Stravix, Stravix Pl |
| Hologic Sales and Service, LLC | $60.66 | 2021-2023 | Aptima |
| Medtronic, INC. | $46.60 | 2024 | Ligasure |
| Stryker Corporation | $45.14 | 2023 | Spy-Phi System |
| Kyowa Kirin, INC. | $35.08 | 2021 | |
| Coherus Oncology, INC. | $35.00 | 2021-2023 | |
| Dilon Technologies, INC. | $28.01 | 2025 | Hemoblast Bellows |
| Pacira Pharmaceuticals Incorporated | $22.31 | 2022 | |
| Lsi Solutions INC | $21.80 | 2023 | Fornisee |
| Mylan Institutional INC. | $18.87 | 2022 | |
| Pfizer INC. | $18.28 | 2025 | |
| Solventum Corporation | $16.55 | 2024 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Dodd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.